Method for increasing the oral bioavailability of S- `2-(``1-(2-ethylbutyl)cyclohexyl!carbonyl !amino)phenyl!-2-methylpropanethioate

Details for Australian Patent Application No. 2004222436 (hide)

Owner Japan Tobacco Inc.

Inventors Urata, Yasuo; Ishikawa, Tomohiro

Agent Griffith Hack

Pub. Number AU-A-2004222436

PCT Pub. Number WO2004/082675

Priority 60/460,521 04.04.03 US; 60/455,293 17.03.03 US; 60/477,202 10.06.03 US

Filing date 17 March 2004

Wipo publication date 30 September 2004

International Classifications

A61K 031/265

A61P 009/10 Drugs for disorders of the cardiovascular system

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/082675 Priority application(s): WO2004/082675

28 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222439-Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer

2004222435-Angiotensin-converting enzyme inhibitory peptides